New clinical trials in CUP and a novel paradigm in cancer classification

被引:0
|
作者
Rassy, Elie [1 ,2 ]
Andre, Fabrice [1 ,3 ]
机构
[1] Univ Paris Saclay, Dept Med Oncol, Gustave Roussy, Villejuif, France
[2] Univ Paris Saclay, CESP, INSERM, U1018, Villejuif, France
[3] Univ Paris Saclay, Gustave Roussy, INSERM, U981, Villejuif, France
关键词
D O I
10.1038/s41571-024-00942-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Precision oncology has reached a milestone as data from two trials in which molecular profiling guided both site-specific and tumour-agnostic therapies indicate improved survival outcomes in patients with cancer of unknown primary. These findings can also be extrapolated and support the use of tissue-agnostic approaches in general, and also suggest that the tissue of origin might have a role in the agnostic classification of cancers and their response to treatment.
引用
收藏
页码:833 / 834
页数:2
相关论文
共 50 条
  • [1] A new paradigm for clinical trials in antibiotherapy?
    Laupland, Kevin B.
    Fisman, David N.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2011, 22 (02): : 39 - 42
  • [2] New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical Trials
    Travis, William D.
    Brambilla, Elisabeth
    Riely, Gregory J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (08) : 992 - 1001
  • [3] Need for a new paradigm for the clinical trials of antidepressants
    Katz, MM
    NEUROPSYCHOPHARMACOLOGY, 1998, 19 (06) : 517 - 522
  • [4] Teletrials: implementation of a new paradigm for clinical trials
    Collins, Ian M.
    Burbury, Kate
    Underhill, Craig R.
    MEDICAL JOURNAL OF AUSTRALIA, 2020, 213 (06) : 263 - +
  • [5] Need for a new paradigm for the clinical trials of antidepressants
    Katz M.M.
    Neuropsychopharmacology, 1998, 19 (6) : 517 - 522
  • [6] Controlled clinical drug trials: creating a new paradigm
    Fine, PG
    PAIN, 2002, 95 (1-2) : 194 - 194
  • [7] In-Silico Clinical Trials as a New Paradigm in Medicine
    Filipovic, Nenad
    2020 9TH MEDITERRANEAN CONFERENCE ON EMBEDDED COMPUTING (MECO), 2020, : 7 - 7
  • [8] Clinical Trials in Pericardial Disease: New Paradigm Shift
    Imazio, Massimo
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (11)
  • [9] Pharmacodynamics of levofloxacin - A new paradigm for early clinical trials
    Preston, SL
    Drusano, GL
    Berman, AL
    Fowler, CL
    Chow, AT
    Dornseif, B
    Reichl, V
    Natarajan, J
    Corrado, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (02): : 125 - 129
  • [10] Clinical Trials in Pericardial Disease: New Paradigm Shift
    Massimo Imazio
    Current Cardiology Reports, 2021, 23